Lymph node classification systems in cutaneous T-cell lymphoma: Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage

E. C. Vonderheid, L. W. Diamond, W. A. Van Vloten, E. Scheffer, C. J L M Meijer, A. W. Cashell, J. M. Hardman, S. M. Lai, J. Hermans, M. J. Matthews

Research output: Contribution to journalArticle

Abstract

Background. This study was undertaken to compare three classification schemes used to evaluate lymph nodes (LN) obtained from patients with cutaneous T-cell lymphoma (CTCL): a modified Rappaport classification, the National Cancer Institute-Veterans Administration (NCI-VA) classification based on the relative numbers of cerebriform cells in the paracortical areas, and the Dutch classification based on the presence of cerebriform cells with large nuclei in mycosis fungoides (MF) and diffuse infiltration by cerebriform cells in Sezary syndrome. Methods. A study set of 195 LN obtained from patients with CTCL (MF, Sezary syndrome, and nonepidermotropic T-cell lymphomas) and 14 LN from patients with benign dermatoses was reviewed independently by three groups of pathologists familiar with each classification system. Results. Each classification system provided useful prognostic information. However, contrary to prior reports, no significant difference in survival was apparent in patients with uneffaced LN when classified according to the NCI-VA (LN0-2 versus LN3) or Dutch (Gr0-1 versus Gr2) ratings. In addition, all classification systems demonstrated a poor survival time associated with effaced LN. By combining results from the modified Rappaport and Dutch classifications, three prognostic groups could be identified based on cell morphology: a low-grade category with a small cell histologic subtype (median survival time, 40 months); a high-grade immunoblastic subtype (median survival time, 9 months) composed of cells with an oval nucleus containing a large, usually solitary central nucleolus; and an intermediate-grade category composed of all cases without the distinctive small cell and immunoblastic morphologies (median survival time, 26 months). Conclusions. The authors propose that clearly involved LN in CTCL can be categorized on the basis of cell morphology into prognostic groups analogous to what has been proposed for the Working Formulation for Non-Hodgkin's Lymphomas for Clinical Usage.

Original languageEnglish (US)
Pages (from-to)207-218
Number of pages12
JournalCancer
Volume73
Issue number1
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Cutaneous T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymph Nodes
Survival
Sezary Syndrome
Mycosis Fungoides
United States Department of Veterans Affairs
National Cancer Institute (U.S.)
T-Cell Lymphoma
Skin Diseases
Cell Count

Keywords

  • classification
  • cutaneous T-cell lymphoma
  • dermatopathic lymphadenopathy
  • mycosis fungoides
  • non-Hodgkin's lymphoma
  • peripheral T-cell lymphoma
  • prognosis
  • Sezary syndrome

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lymph node classification systems in cutaneous T-cell lymphoma : Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage. / Vonderheid, E. C.; Diamond, L. W.; Van Vloten, W. A.; Scheffer, E.; Meijer, C. J L M; Cashell, A. W.; Hardman, J. M.; Lai, S. M.; Hermans, J.; Matthews, M. J.

In: Cancer, Vol. 73, No. 1, 1994, p. 207-218.

Research output: Contribution to journalArticle

Vonderheid, EC, Diamond, LW, Van Vloten, WA, Scheffer, E, Meijer, CJLM, Cashell, AW, Hardman, JM, Lai, SM, Hermans, J & Matthews, MJ 1994, 'Lymph node classification systems in cutaneous T-cell lymphoma: Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage', Cancer, vol. 73, no. 1, pp. 207-218. https://doi.org/10.1002/1097-0142(19940101)73:1<207::AID-CNCR2820730136>3.0.CO;2-C
Vonderheid, E. C. ; Diamond, L. W. ; Van Vloten, W. A. ; Scheffer, E. ; Meijer, C. J L M ; Cashell, A. W. ; Hardman, J. M. ; Lai, S. M. ; Hermans, J. ; Matthews, M. J. / Lymph node classification systems in cutaneous T-cell lymphoma : Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage. In: Cancer. 1994 ; Vol. 73, No. 1. pp. 207-218.
@article{b6361c9fe65f4195b2f403c6a96b002b,
title = "Lymph node classification systems in cutaneous T-cell lymphoma: Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage",
abstract = "Background. This study was undertaken to compare three classification schemes used to evaluate lymph nodes (LN) obtained from patients with cutaneous T-cell lymphoma (CTCL): a modified Rappaport classification, the National Cancer Institute-Veterans Administration (NCI-VA) classification based on the relative numbers of cerebriform cells in the paracortical areas, and the Dutch classification based on the presence of cerebriform cells with large nuclei in mycosis fungoides (MF) and diffuse infiltration by cerebriform cells in Sezary syndrome. Methods. A study set of 195 LN obtained from patients with CTCL (MF, Sezary syndrome, and nonepidermotropic T-cell lymphomas) and 14 LN from patients with benign dermatoses was reviewed independently by three groups of pathologists familiar with each classification system. Results. Each classification system provided useful prognostic information. However, contrary to prior reports, no significant difference in survival was apparent in patients with uneffaced LN when classified according to the NCI-VA (LN0-2 versus LN3) or Dutch (Gr0-1 versus Gr2) ratings. In addition, all classification systems demonstrated a poor survival time associated with effaced LN. By combining results from the modified Rappaport and Dutch classifications, three prognostic groups could be identified based on cell morphology: a low-grade category with a small cell histologic subtype (median survival time, 40 months); a high-grade immunoblastic subtype (median survival time, 9 months) composed of cells with an oval nucleus containing a large, usually solitary central nucleolus; and an intermediate-grade category composed of all cases without the distinctive small cell and immunoblastic morphologies (median survival time, 26 months). Conclusions. The authors propose that clearly involved LN in CTCL can be categorized on the basis of cell morphology into prognostic groups analogous to what has been proposed for the Working Formulation for Non-Hodgkin's Lymphomas for Clinical Usage.",
keywords = "classification, cutaneous T-cell lymphoma, dermatopathic lymphadenopathy, mycosis fungoides, non-Hodgkin's lymphoma, peripheral T-cell lymphoma, prognosis, Sezary syndrome",
author = "Vonderheid, {E. C.} and Diamond, {L. W.} and {Van Vloten}, {W. A.} and E. Scheffer and Meijer, {C. J L M} and Cashell, {A. W.} and Hardman, {J. M.} and Lai, {S. M.} and J. Hermans and Matthews, {M. J.}",
year = "1994",
doi = "10.1002/1097-0142(19940101)73:1<207::AID-CNCR2820730136>3.0.CO;2-C",
language = "English (US)",
volume = "73",
pages = "207--218",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Lymph node classification systems in cutaneous T-cell lymphoma

T2 - Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage

AU - Vonderheid, E. C.

AU - Diamond, L. W.

AU - Van Vloten, W. A.

AU - Scheffer, E.

AU - Meijer, C. J L M

AU - Cashell, A. W.

AU - Hardman, J. M.

AU - Lai, S. M.

AU - Hermans, J.

AU - Matthews, M. J.

PY - 1994

Y1 - 1994

N2 - Background. This study was undertaken to compare three classification schemes used to evaluate lymph nodes (LN) obtained from patients with cutaneous T-cell lymphoma (CTCL): a modified Rappaport classification, the National Cancer Institute-Veterans Administration (NCI-VA) classification based on the relative numbers of cerebriform cells in the paracortical areas, and the Dutch classification based on the presence of cerebriform cells with large nuclei in mycosis fungoides (MF) and diffuse infiltration by cerebriform cells in Sezary syndrome. Methods. A study set of 195 LN obtained from patients with CTCL (MF, Sezary syndrome, and nonepidermotropic T-cell lymphomas) and 14 LN from patients with benign dermatoses was reviewed independently by three groups of pathologists familiar with each classification system. Results. Each classification system provided useful prognostic information. However, contrary to prior reports, no significant difference in survival was apparent in patients with uneffaced LN when classified according to the NCI-VA (LN0-2 versus LN3) or Dutch (Gr0-1 versus Gr2) ratings. In addition, all classification systems demonstrated a poor survival time associated with effaced LN. By combining results from the modified Rappaport and Dutch classifications, three prognostic groups could be identified based on cell morphology: a low-grade category with a small cell histologic subtype (median survival time, 40 months); a high-grade immunoblastic subtype (median survival time, 9 months) composed of cells with an oval nucleus containing a large, usually solitary central nucleolus; and an intermediate-grade category composed of all cases without the distinctive small cell and immunoblastic morphologies (median survival time, 26 months). Conclusions. The authors propose that clearly involved LN in CTCL can be categorized on the basis of cell morphology into prognostic groups analogous to what has been proposed for the Working Formulation for Non-Hodgkin's Lymphomas for Clinical Usage.

AB - Background. This study was undertaken to compare three classification schemes used to evaluate lymph nodes (LN) obtained from patients with cutaneous T-cell lymphoma (CTCL): a modified Rappaport classification, the National Cancer Institute-Veterans Administration (NCI-VA) classification based on the relative numbers of cerebriform cells in the paracortical areas, and the Dutch classification based on the presence of cerebriform cells with large nuclei in mycosis fungoides (MF) and diffuse infiltration by cerebriform cells in Sezary syndrome. Methods. A study set of 195 LN obtained from patients with CTCL (MF, Sezary syndrome, and nonepidermotropic T-cell lymphomas) and 14 LN from patients with benign dermatoses was reviewed independently by three groups of pathologists familiar with each classification system. Results. Each classification system provided useful prognostic information. However, contrary to prior reports, no significant difference in survival was apparent in patients with uneffaced LN when classified according to the NCI-VA (LN0-2 versus LN3) or Dutch (Gr0-1 versus Gr2) ratings. In addition, all classification systems demonstrated a poor survival time associated with effaced LN. By combining results from the modified Rappaport and Dutch classifications, three prognostic groups could be identified based on cell morphology: a low-grade category with a small cell histologic subtype (median survival time, 40 months); a high-grade immunoblastic subtype (median survival time, 9 months) composed of cells with an oval nucleus containing a large, usually solitary central nucleolus; and an intermediate-grade category composed of all cases without the distinctive small cell and immunoblastic morphologies (median survival time, 26 months). Conclusions. The authors propose that clearly involved LN in CTCL can be categorized on the basis of cell morphology into prognostic groups analogous to what has been proposed for the Working Formulation for Non-Hodgkin's Lymphomas for Clinical Usage.

KW - classification

KW - cutaneous T-cell lymphoma

KW - dermatopathic lymphadenopathy

KW - mycosis fungoides

KW - non-Hodgkin's lymphoma

KW - peripheral T-cell lymphoma

KW - prognosis

KW - Sezary syndrome

UR - http://www.scopus.com/inward/record.url?scp=0028157920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028157920&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19940101)73:1<207::AID-CNCR2820730136>3.0.CO;2-C

DO - 10.1002/1097-0142(19940101)73:1<207::AID-CNCR2820730136>3.0.CO;2-C

M3 - Article

C2 - 8275427

AN - SCOPUS:0028157920

VL - 73

SP - 207

EP - 218

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -